Objective: To assess the fetomaternal outcome in subjects of severe PET. Method: This prospective descriptive study (case series) was carried out in department of obstetrics & gynecology, Govt. Medical College, New Civil Hospital Surat, enrolling 142 subjects with severe Preeclampsia (Severe PET) admitted in labour room at new civil hospital, surat over a period of two years from august 2010 to july-2012 & followed till discharge. Summary: This study was conducted at new civil hospital, surat enrolling subjects admitted with severe PET (n=142). The incidence of severe PET amongst our labour room admissions was 1.2%. All patient were given labetalol for control of hypertension, but labetalol alone was sufficient in 74.49% subjects and other anti-hypertensive were needed in 25% subjects. MgSO4 sulphate prophylaxis was administered in 72 out of 142 subjects with severe PET- none of whom developed subsequent eclampsia. 66.9% delivered vaginally, 6.9% had assisted vaginal delivery while 26.1% had CS. Adverse maternal outcome was noted in 34% subjects, abruptio placenta was the commonest complication noted in 10.3% subjects and maternal mortality in 3.9% subjects. Adverse fetal outcome was seen in 11.8% subjects – prematurity accounting for 85.2% of the adverse fetal outcomes. Conclusion: Maternal mortality and morbidity increases in subjects with severe pre-eclampsia so it is important for clinicians to educate women about the early warning sign of pre-eclampsia and to identify women with severe PET. Labetalol is an effective drug to control the severe hypertension noted in pre-eclampsiaand MgSO4 is very effective to prevent convulsion in severe PET.